嘉宾访谈·中文精读

马丁·什克雷利:大型药厂的盲点、押注量子计算失败与监狱教会他的事

Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him

马丁·什克雷利谈为何做空量子计算、大药厂的定价盲点、从对冲基金转向制药,以及 AI 药物发现和监狱教训。

官方音频00:00 / --:--

本期章节点时间可跳到音频对应位置

  1. 0:00马丁·施克莱里做客好友团!
  2. 0:55为何量子计算是一门独门生意、他为何做空它
  3. 7:42大型药企卖得太便宜的药、他从对冲基金交易员到药企的历程
  4. 11:37AI、药物发现与谁真正获胜
  5. 21:32才华与破规、神童陷阱及监狱教会他的事
中文精读由 AI 基于原始节目改写,非官方翻译,可能存在偏差或错误;观点归属与表述以原音频与官方文稿为准。说明

马丁·什克雷利(Martin Shkreli)说,他和妻子切尔西(Chelsea)把全世界每一台量子计算机都试了一遍。

没有一台能算出 300 乘 200。

这个名字留给多数人的印象停在 2015 年:他把一种救命药的价格上调 5000%,被媒体叫成"美国最被讨厌的人",随后因证券欺诈入狱七年。出狱之后他干了件让硅谷不太舒服的事,公开唱空量子计算,而且真的下了空单。

他在 All-In 这期节目里的说法很直白:亏了几百万美元,但赚到了几十亿美元的认知。

同一个人,2015 年买下吴唐家族(Wu-Tang Clan)那张全世界只有一份的专辑,后来说自己没打算放来听,因为"这不是一张好唱片"。

切尔西的背景值得交代一句。她是 OpenAI 最早期的员工之一,在 MIT 读书时跟斯科特·阿伦森(Scott Aaronson)一起教量子计算。什克雷利说,她花了很多个小时,把量子计算到底是个什么东西,硬塞进了他那颗"很厚的脑袋"里。

整个领域只赢在一个算法上

公众习惯把量子计算理解成"更快的计算机"。什克雷利的说法是,这个理解从一开始就跑偏了。

领域的起点是彼得·肖尔(Peter Shor)的算法:量子计算机能在多项式时间内完成整数分解和椭圆曲线离散对数问题(ECDLP)。这两件事在经典计算机上是指数级难度,也是今天大部分公钥加密的地基。

问题在于,到此为止了。

他举了个例子。算法教科书 CLRS 前几页讲排序,冒泡排序、归并排序那一套。他问量子发烧友,哪种计算机排序更快,对方说当然是量子计算机。他说完全不是:现代量子计算机的时钟频率是几百到几千赫兹,不是我们习惯的吉赫兹;做归并排序这类任务时,它是单核单线程的。

对一个极客来说,这是史上最酷的魔术。但对一个生意人来说,除非你的生意就是分解数字,这里没什么可兴奋的。(什克雷利)

还有存储。量子世界没有量子内存这种东西。你设计的题目输入必须极小,不可能把全世界的算力塞进去。

你愿意做多打孔卡吗

节目里有人替量子计算说了句公道话:也许我们正处在晶体管的原始阶段,先把门电路搞明白,再搭逻辑,再写操作系统,这些现在都还不存在。

什克雷利承认这个类比成立,但反问了一句:那你愿意做多打孔卡、真空管、水银延迟线和磁芯存储器吗?

这些东西在历史上都真实存在过,有些还是上市公司。它们全都消失了,公司也破产了。他的判断是,量子计算的问题既是技术问题,也是商业模式和时机问题。

他问过谷歌、IBM、微软的人,每年砸几亿美元在这上面图什么。得到的回答大致是"也许某天会有点东西出来"。

这对我来说不是一门好生意。(什克雷利)

现实层面的数字更直白:谷歌有几台原型机,IBM 有一个小规模的云服务。全世界能用的量子计算机,数量少到他和妻子可以挨个试完。

做空这些公司让他亏了钱,他不否认时机很难把握。

光里的矩阵乘法是免费的

否定量子之后,他给了一个正面判断:二十年后的 H100、B100、B200 都会躺在废品堆里。

他翻《自然》杂志时看到微软的一篇论文,主题是模拟光计算(Analog Optical Computing,AOC)。论文里让他眼前一亮的一点是,光中的矩阵乘法是"免费"的,几乎瞬时完成。

这里要解释一下矩阵乘法在今天的地位。什克雷利说,每次听到有人讲 AI,他脑子里跳出来的词是 Matmul。GPU 99.9% 的时间都在做两个数字列表相乘,复杂度是 n 的三次方:一千乘一千的矩阵相乘,是十亿次运算。

如果这件事能交给光来做,账就完全变了。他提到几家在做光子矩阵乘法核心的创业公司,Neurofoss、OptiCore、Lumai,说这些芯片能把英伟达甩开一大截。他也承认,非线性、存储这些环节还有大量细节没解决。

萨姆·奥特曼(Sam Altman)后来在另一个播客上公开说,光子计算可能是未来。什克雷利的疑问是:我们为什么觉得把地球铺满计算机是个理智的方案,而不是先把单台机器做快一点。

200 万美元买一个没人要的药

话题转回他的老本行。

他 16 岁进吉姆·克莱默(Jim Cramer)的对冲基金。他给了克莱默一个相当高的评价:非常有效、非常有技巧的交易员。克莱默的做法是每天买卖所有东西,居然还能从里面挤出利润,扣费后年化 23%。

后来他去了 Tiger Cub 体系,再后来自己开基金。他给自己的定位很明确:做交易员不如做创业者和私募股权的人。

他发现的套利空间在分子市场。上市公司市场很有效,药物资产的市场极其低效。

我从百时美施贵宝手里花 200 万美元买了一个药,那家公司今天还上市,值 60 亿美元。辉瑞会把一个值十亿美元的药,一百万卖给你,他们不在乎。(什克雷利)

他在节目开头还说过一句更刺耳的话:在美国,一家公司如果不把利润最大化,反而可能被起诉。

这门生意的瓶颈不在钱,在带宽。要有人读论文、读专利、跑大学和小药厂、和大药厂建立关系,行业里管这叫商务拓展。当年全美一年发表 4000 万篇医学论文,靠人读完是不可能的。他 2015 年顺手做了个自然语言处理的小公司,想用机器把这些论文读完。

三万人的第一种药

具体怎么做,他给了一个例子。

百时美施贵宝开发过一个治高血压的分子,高血压是个死气沉沉的市场,谁都不缺降压药。什克雷利把这个分子重新命名,转向一种叫 FSGS(局灶性节段性肾小球硬化)的罕见肾病。这种病此前从未有过获批药物。

结果这个药拿到了 FDA 批准,成了重磅药。全美约三万名 FSGS 患者,第一次有了对症的药。

我也可以做个好人。(什克雷利)

这句话他说得半开玩笑,背后的逻辑却很严肃:同一颗分子,在一个人满为患的市场里是废纸,在一个无人问津的适应症里是救命药。发现这件事需要的不是化学,是对市场错配的敏感。

节目里有人把这家公司和 Royalty Pharma 类比,什克雷利说不太一样。Royalty 的成名作是从纽约大学手里买下 Remicade 的一份特许权,价格大约是盈利的一倍,后来那份现金流涨了二十倍。

千倍更好的 Transformer 会杀死英伟达

布拉德·格斯特纳(Brad Gerstner)把话题拉到当下的算力资本开支,问他怕什么。

什克雷利先说结论:他目前做多半导体。

他提到杰文斯悖论(Jevons Paradox),效率提高反而让总消耗上升。Alex Wang(Scale AI 创始人汪滔)跟他讲,算力会有一百万倍的提升。但话锋一转:

如果山谷里有人做出了效率高一千倍的 Transformer,那对英伟达是坏消息,这点没有疑问。(什克雷利)

他说的是需求曲线会被改写。一百倍的效率提升,意味着原来要一百万张卡的任务现在一万张就够。多出来的人不会凭空出现。

他也没把话咬死。他说自己的猜测和所有人一样,长期看多,但 2000 年的时候,很多人也觉得雅虎和思科是应该长期持有的。

他为什么恨达里奥

主持人问他怎么看达里奥·阿莫代伊(Dario Amodei)那篇文章。

他先给了个敬意:把公司做到万亿美元不容易。紧接着补了一句,我有点恨这个人。

分歧不在技术路线,在叙事方式。

假设你和我一起创业,你跟我说,我给你看个东西,这叫潘多拉魔盒。我说太厉害了。然后你说,谢谢,我上街开另一家潘多拉魔盒公司。你猜我会怎么做,我大概会告你窃取商业机密。(什克雷利)

这说的是阿莫代伊从 OpenAI 出走创办 Anthropic 的往事。什克雷利强调自己不知道当年到底发生了什么,也不想替谁定罪,但他觉得这套叙事站不住:一边说这东西危险到需要全人类警惕,一边自己开公司把它做出来卖。

他顺手举了安东尼·莱万多夫斯基(Anthony Levandowski)的例子,那位 Waymo 前工程师因为带走文件被判了刑。

他还提到自己参与推动过 e/acc(有效加速主义,Effective Accelerationism),名字是故意对着 EA(有效利他主义)取的,骨子里是一场反叛。他的判断很简单:现在是关掉电脑就能解决问题的时代,还没到该恐慌的时候。

这就是计算机科学,没那么大件事。有些书呆子一被聚光灯照到就慌了,他们不说"一切正常",反倒想方设法把注意力引到自己身上。(什克雷利)

他对 Meta 和黄仁勋的评价是"有骨气",敢直接说这是胡说八道。

AI 造不出药

阿莫代伊说过 AI 会治愈所有疾病,还说一到五年内人类会全面失业。什克雷利对这两句都不买账。

我不认为未来十年会有一个和 AI 相关的药物出现。AI 帮不上药物发现的忙。(什克雷利)

他让在场做过药、拿过 FDA 批准的人举手,没人举。他补了一句自己的履历:他搭过 Cray 集群分析药物,现在这些活可以用 GPU 干,很好用,但也就到此为止。

这个判断值得停一下。计算机辅助药物设计已经做了三十年,真正的瓶颈一直在生物学,不在算力。一个分子在体外有效、在动物身上有效、在人体上有效、副作用可控,这四道门每一道都要靠实验筛,浮点运算加速不了其中任何一道。

无限智能,和一家叫 OpenAI 制药的公司

关于 AI 的市场空间,他和布拉德有明显分歧。

布拉德在算 TAM 时把可寻址市场限定在知识工作者,什克雷利认为这是自我设限。他的说法是,对智能的需求和对工作的需求都是无限的。

他举了个例子:麦当劳完全可以花 100 亿美元,要一千万张 GPU,问它下一款该推什么三明治。如果智能真的值这个钱,这笔买卖的净现值就是正的。

他还提到一个朋友从 OpenAI 离职,创办了一家叫 Core Automation 的公司,此人是 OpenAI 推理模型的发明者。他的预测是,OpenAI 内部会长出 OpenAI 制药、OpenAI 汽车、OpenAI 航空,每一块最后都相当于一个标普 500。

被问到"你今天会不会买 OpenAI 和 Anthropic",他的回答是会。他认为奥特曼在硬件上的对冲极为聪明:模型领先未必能永远保持,但能把这个模型交付到用户手里,价值更大。

他把这一波类比成互联网。互联网真正的大赢家是消费者和企业,思科只分到一小杯。免费智能已经在每个人的口袋里。至于谁会被过度奖励、这段超额收益能持续多久,他说这更像是一个择时问题,而他认为现在是 Meta 的位置:有分发,产品能力也还在,AI 还处在第一天的阶段。

主持人还问他怎么看马斯克提的竞争对手互审(competitor peer review)这个折中方案。他的回答绕到了尼克·博斯特罗姆(Nick Bostrom)那本《超级智能》,说这本书把马斯克吓得不轻。

天赋是一种负担

节目后半段转向一个更私人的话题。

主持人提出一个观察:最聪明的人往往是非共识的思考者,正因为不守常规才有超额收益,也同样因为不守常规,很难在"守法"这件事上保持常规。

什克雷利顺着这个思路讲了萨姆·班克曼-弗里德(Sam Bankman-Fried)。他承认自己给过对方建议,让他扛住。他看 SBF 2021 到 2022 年的投资组合,Anthropic、Robinhood,那个组合在当时看来像天才。

他给的诊断是:

如果你从小被当作智力超常的人养大,你身上就背着一个很大的包袱。你得配得上点什么。(什克雷利)

他点了三个名字:伊丽莎白·霍姆斯(Elizabeth Holmes)、拉杰·拉贾拉特南(Raj Rajaratnam)、SBF。三个人都在某个领域极其聪明,都在另一个领域极其愚蠢。

然后是这段访谈里最诚实的一句自我剖析:

我很难承认自己不是世界上最好的对冲基金经理,但我是一个出色的创业者。就是不肯承认这一点,把我送进了监狱。(什克雷利)

监狱里最普通的发现

被问到监狱教会了他什么,他没有讲什么惊心动魄的故事。

他说,不管一个人来自哪里、做了什么,身上都有一些把人类绑在一起的共同点。每个人都为某个朋友没再联系自己而难过,都在思念某个人。

不管你爬到多高,在最底下,我们都只是想做个好爸爸,或者别的什么。(什克雷利)

他讲的是心理学的力量:所有行为背后都有我们自己也不完全理解的驱动力。他当年没意识到自己有多害怕不被看作伟大的交易员。他说这想法多愚蠢,你可以是个好的长期投资者、好的创业者、好的父亲、好的科学家,但如果你把自己的心钉死在"我必须成为这一种人"上,代价会很大。

节目最后,主持人说他是独立的思想者,愿意用别人不会用的方式说话,这也是请他来的原因。

  • 判断一项新技术,先问它能跑几个算法。量子计算目前只在整数分解和椭圆曲线离散对数这一个场景里赢,其余任务被经典芯片碾压。同样的问法可以套到任何被吹上天的技术上。
  • 看英伟达要多看一条曲线。需求增长的故事成立,但效率提升一千倍的模型架构一旦出现,就是需求侧的通缩。做多算力和做多模型效率,是两个不同的赌注,仓位别混在一起。
  • 去低效市场里找错配。辉瑞一百万卖掉的药,换个适应症就是十亿美元。这个逻辑在今天的 AI 应用层同样成立:通用模型不值钱,值钱的是把它塞进一个没人愿意看的窄场景。
  • 评估 AI 制药的说法,先数一数有多少人真的走完过一整个 FDA 流程。算力能加速筛选,加速不了临床。
  • 如果你恰好是某个领域的天才型选手,给自己留一句退路:承认自己不是最好的那个,成本远低于硬撑。什克雷利用七年时间换来这句话。
文稿由本站用语音识别模型(Whisper,基于官方发布音频)机器转写,可能有识别错误,没有说话人标注;人名与数字请以音频为准。
(00:00:00) He's been called the most hated man in America because he jacked up the cost of a life-saving drug. Raised the price of a life-saving drug 5,000%. He became the poster child for capitalistic greed. Martin Shkreli, seven years in prison. We definitely plan on raising the price, that's for sure. You can be prosecuted for not maximizing profit. And you have to do everything in your power to make as much money as possible. And if I'm the enemy for you, good, I'm happy, man. I'm fulfilling some need in your life. Purchased the only copy of a legendary Wu-Tang Clan album with no immediate plans to play it. It's not a good record. Ego is the fountainhead of all progress. Please welcome Martin Shkreli. Welcome Martin, thanks for coming out. (00:00:45) Nice to meet you. You wore Brad's outfit today. Exactly. Alright, welcome Martin. We got so many topics to go into with you, but I want to start with one. You've basically taken down quantum computing. You said you'd think that this is a fraud, that people might be going to jail. So, two-part question. Number one, maybe you could give us your thesis on why this is a fraud or fugazi, a fugizi, whatever it is. Disgraciad. And a disgracead. And then two, your best advice for those CEOs when they do go to jail, you've got a little experience. Oh yeah. Yeah. Best advice in terms of, you don't seem to be the kind of guy who would thrive in prison, but from what I understand, Martin... (00:01:36) You're like a shock caller. Hold on. You're like a shock caller in prison. You turned into Lex Luthor and you were running the yard, I understand. So, break us through the quantum trade and best practices when you go to the Huskau. Yeah, so I have to shout out my wife, Chelsea. So, Chelsea, very few people know her, but she's, I think, a big deal in technology. She was one of the first people at OpenAI. And her father, believe it or not, was one of the first people at NVIDIA. In my family, I was one of the first people in prison. So, I thought I'd switch the gene pool, you know, shift it over a little bit. But Chelsea taught, studied at MIT and taught quantum computing with Scott Aronson, the preeminent guy in quantum. And, you know, we, she got to teach me over many hours, you know, penetrated my thick head, you know, what exactly quantum computing even is. (00:02:26) And I think a lot of people sort of synonymize it with faster computing, which sounds great. That's really not what it is at all. And I think the basic point of quantum computing is that there's one algorithm. In fact, the whole field was invented because of Peter Schor's thought experiment. Peter considered this idea that there are kinds of algorithms that you can run faster in different media. That was a revolutionary idea in computing. But it's not really a revolutionary idea for business because, and this is my thesis, of course, because there's one algorithm. That runs faster in a quantum computer. And so if you ask somebody, which computer can sort a deck of cards? If anybody, you know, the famous algorithm's book, CLRS, you know, the first five pages are about sorting algorithms, like bubble sort and merge sort and things like that. And I asked quantum fans, well, which one can sort it faster? (00:03:13) And they said, well, of course, the quantum computer. And I said, of course not. That's not the case. The modern quantum computers run at a clock speed of hundreds of hertz or thousands of hertz, not at the gigahertz that we're used to. They're single core and they're single threaded when it comes to doing a job like a merge sort or something like that. So the only thing it's really good at, which indeed is a magic trick, is going from exponential time algorithm, which is integer factorization or elliptic curve discrete log problem, which I want to mention a little later. Shout out to the ECDLP problem. The quantum computers can do those in polynomial time, which is remarkable. And to a nerd, that's the greatest, coolest magic trick ever. But to a business person, unless you were in the business of factoring numbers, there's not a whole lot to be excited about here. So the other algorithms that quantum could do are not much faster. (00:03:58) So they'll never beat an NVIDIA machine. They'll never beat a million NVIDIA machines. And quantum doesn't have storage. There's no such thing as quantum RAM. So you have to design a problem that has a really, really small input. You cannot put the world's compute into it. Every time somebody pitches OpenAI, from what I've heard about quantum computer, they say, no, we're not interested. I think I'm closer to you in my perspectives on quantum. But let me take the other side. Let's just take the other side. The other side would say, look, we're in this very early primordial phase of actually constructing the transistor. And from the transistor, what we're going to do is put a bunch of these things together. We're going to figure out gates. We're going to figure out logic. We'll then be able to build some reasonable operating system on top of it. We'll have some reasonable mechanisms to write software to these things. (00:04:46) And none of that really exists. So do you buy that we're just at an early phase and this is why we're frustrated that there's a computational limitation except to a very narrow use case? Like, do you believe that that could be possible? Yeah, no, of course. I think the issue, though, is do you buy, would you go long punch cards and vacuum tubes, right? Mercury delay lines, core memory. These are all things that disappeared and went bankrupt. Those were stocks at one point. CTR, you know, computer tabulator machine got incorporated into IBM. Okay, so your critique is business model and timing or is it technological? I think it's both. You know, I think that when you talk to Google or IBM or Microsoft and ask them why are you spending hundreds of millions of dollars a year on this? They say, well, someday there might be something that comes out of it. That's not a great business to me. (00:05:31) Well, it is very shocking. I mean, you can probably tell the story, but how many machines actually, how many machines does IBM and Google actually have? Very few. So Google has a few prototypes. IBM has a little cloud. Chelsea and I have tried every single quantum computer in the world. We cannot multiply 300 by 200 on any of these. And you're shorting them? Yeah, I've been short them. Unfortunately, we lost millions of dollars shorting quantum computing companies, but I told my wife that we gained billions in insight. Right. It's not easy to time the markets. Yes. Definitely. So where is the natural computational edge? I mean, some people would say it's going to be towards encryption and defeating encryption because now we can actually use what it's actually good at to essentially brute force solutions to things that we can't solve today. (00:06:17) I think it's crazy to even think about it because we have a computational problem that we're trying to solve. And every time somebody uses the word AI, I actually think of the word Matmul. These are Matmul machines. And I think that as we... Matrix multiplication is what he's referring to. Right. So multiplying two lists of numbers is what a GPU spends 99.9% of its time doing. Sure. But it does it in n-cube time. Now, what's funny, I think things like complexity algorithms are going to be parlance, you know, in the next five to ten years as we move towards a society. So n-cube means if you want to multiply a thousand element square matrix versus another thousand element square matrix on an NVIDIA machine, it takes a billion operations. That's a lot of operations. As we learned about this computing stuff through my lovely wife, I was flipping through nature, which is what we do as a hobby, and I saw a paper from Microsoft that was called AOC, Analog Optical Computing. (00:07:11) In New York, that means something different, but AOC in this case is... Yeah. And what I saw in the corner of my eye was that Matmuls in light are free. Yeah. They happen in instant time, which is a really remarkable thing. So we're investigating, maybe we'll start a company or something like that, but there's a couple of things that we're doing. There's a couple of startups like Neurofoss, OptiCore, Lumai that want to make these photonic Matmul cores, which would run circles around what NVIDIA does. Now, of course, that's not the whole story. There's a lot of details and non-linearity and storage. So just beyond the hatred for quantum and your raging short that may or may not be winning, you were a hedge fund manager, correct? And the famous episode, just to catch everybody up, was you bought a drug and then you inflated the price of the drug. (00:08:00) Is that what happened? Can you just give us the history and what takes you now to... Yeah, I started at 16 at Jim Cramer's hedge fund. Cramer was actually a tremendously effective and skilled trader. But Cramer's idea of investing was to buy and sell all day, every day, everything. And he somehow squeezed profits out of it. That was the way you do it sort of in the 80s and 90s. And he actually made 23% a year, net of fees. And so you worked for him as a 16-year-old? I worked for him at 16. How did you get that job? Just being in Manhattan, having a big mouth, and you know, it's a great city. And loving stocks, loving investing. Bill Gates was my hero. And I found a way to, you know, get into that. And Cramer one day pointed at me and said, Genomics, you're going to look at Genomics! And I said, okay. (00:08:46) And it was a lot of fun and I went to a Tiger Cub. I started my own fund. I realized I was a much better entrepreneur and private equity guy than a trader. We found that the marketplace for molecules had huge amounts of alpha, whereas the marketplace at public companies, we could buy a drug from, I bought a drug from Bristol Myers for $2 million. And that same company is public today. It's worth $6 billion. So that was my first startup. And it was a really inefficient market. Pfizer would sell you a drug for a million bucks that was worth a billion dollars. They didn't care. Sell you the rights to the drugs. You can productize it, price it. Yeah, absolutely. I'm sorry. What do you mean? You just knock on Pfizer's door and they're like, take what you'd like for a million dollars. We saw this and we built two very similar companies that, our biggest constraint was finding people to vet these assets. (00:09:33) So I started a small NLP. Clinically. Yeah, just reading papers, reading patents, going to universities and small drug companies and big drug companies, making relationships. It's called business development in our field. And our biggest bandwidth problem was reading these papers. So I started a small NLP company on the side in 2015. We had Watson. It was great. And we tried to read every... It wasn't great. We tried to read every paper that was published in medicine. It was 40 million papers. And having humans do that is a really tough thing. How do you take a molecule and flip it from 25 million to six? But what are you doing in that six or nine months that you own it? I think so. What I did with Sparsantan, a drug that I named and is now FDA approved, now a blockbuster drug, is Bristol discovered and developed it for hypertension, (00:10:18) which is sort of a dead, sleepy market that nobody really needs. Hypertension, high blood pressure. Yeah. And so we moved into a disease called FSGS, which is a disease that never has had a drug approved for it. So you sort of try to angle it in a way that makes sense. And in that case, the drug got FDA approved. 30,000 people who have focal segmental glomerular sclerosis and never had a drug before now have a drug. I can be a good guy too. And I think the, you know, that was, you know, it's the art of that field. It's a great way to make a billion dollars. It's a... Is this what Royalty Pharma does? Roy Vant. But is this also what Royalty Pharma does? They'll come in? Yeah, Royalty's a bit of a different player. Genius guys, obviously. Their big claim to fame was they went to NYU, it was getting this big royalty from Remicade, and they bought it for like one times earnings. (00:11:04) Yeah. And then that royalty 20X'd. They buy the cash flows at a bigger discount than how they're being... Brad, I know you want to get in here, so jump in here. Martin, take this framework now. You know, you know, kind of the big levers in the market today, right? What's expected in terms of compute, what's expected in terms of this CapEx build out. Are you spending much time looking at that? And do you see any boogeymen there? What are you worried about? What would you be shorting? What would you be long in that complex? Yeah, I mentioned photonic computing before, because I do think in 20 years these H100s are in the scrap heap. B100s are in the scrap heap. B200s are in the scrap heap. We're going to find ways to do this better. I think it's insane that we're thinking about space. I think it's insane we're thinking about nuclear. Sam Altman finally said publicly that he thinks photonic computing is on a rival podcast. That photonic computing could be the future. (00:11:51) So I'm just wondering why we think this is a sane idea to cover the earth with computers when we can make a faster one. I think that that doesn't mean NVIDIA is not along. And I'm long semis right now. I think Jevin always wins in the end. Everyone Jevin's paradoxes, you know, the crap out of everything. Alex Wang told me Jevin's going to, you know, take care of all this. It'll be a million X compute improvement. There are guys in the valley talking about better transformers that are a thousand times better. If there's a thousand times more efficient transformer, that's bad for NVIDIA. There's no doubt about that. So, you know, we're not going to have a million X demand. Now we might in another way, but there aren't a million X more people. You know, whether we have a million X more compute needs, you know, we'll have to see. (00:12:36) For now, I think there's, you know, my guess, like anybody else's, is long, but I probably would have guessed in 2000 that Yahoo and Cisco belongs too. So it's a tricky place. So how do you manage, do you run a hedge fund still? I don't. Okay. So you're managing your own money. When you think about portfolio allocation, are you thinking about it in the way you did when you ran your fund? Are you looking for specific high alpha events or startup or disruption and really going long behind those and not really thinking about competing with the market? Yeah, I'm sort of nimble. I mean, I think this Dario trade was like a great reason to go long. So I sort of piled in, you know, onto the sphere. But I really, I don't. The sell off yesterday was sort of like just a head fit. Yeah, I think it was ridiculous. Yeah. What do you think about his essay? I think, I think that I want to pay deference to him creating a trillion dollar company, but I kind of hate the guy. (00:13:27) And I think that he, you know, it's not easy to make a trillion dollar company. Why do you hate him? I think he's a fear monger. I mean, I also think that he, you know, imagine you and I started a business and I said, I'm going to show you Pandora's box. Here it is. And you say, wow, that's amazing. And he said, thanks a lot, Martin. I'm going down the street. I'm going to start Pandora's box too. So what are you doing? You know, it would, I would probably sue you for trade secrets or something. This is exactly what happened. So you're saying because he was at open AI and then he and his five or six co-founders leave. You're saying that like, would you be, would you be friends with that guy? Would you like that? Well, I mean, I think the thing with Silicon Valley is that it kind of happens a lot. Um, and you know, it's, it's sort of hard to pinpoint what is a patent versus what is, you know, retained knowledge. (00:14:15) I'm not excusing it. I'm not saying I know it's anything that happened, but, um, The Waymo guy went to jail for it. Well, I think that that was because he was found to have actually stolen physical documents that were, um, okay. So you have, you have, uh, uh, an issue with sort of the origin story. The fear mongering, the ridiculous, you know, hyperbole, right. You know, he says the AI is going to help drug development. Well, let me ask you more about effective altruism. Yeah. Even worse. Why? Why is, what do you find so loathsome about this group of people? Let's unpack it. Yeah. So, so I helped popularize and I even think I would say start the EAC movement, which was this counter insurgency. I think that. Sorry, there's EA. (00:15:00) Yes. And then there's EAC. Which was intentionally named. EA is effective altruism. EAC is. Effective accelerationism. Effective accelerationism. Which means. Which means. That's a great question. Uh, it may, it, it does mean sort of move fast and break things. And, you know, it's no secret that Zuckerberg came out the other day and said, you know, we should move fast in AI. I think the fear mongering is, is a little ridiculous and there'll be a time to panic. It's just not now. Um, physically I presents those opportunities, you know, for now, I mean, uh, you can turn off the computer. It's, it's, it's not that big of a deal. I think nerds get carried away. Um, you know, if, if you ever were a nerd or a jock, I was, believe it or not, a little bit of both. Uh, the jocks know what to do when they're the spotlights on them, you know, the nerds don't and they clam up and some of them, instead of saying everything's fine, they want to draw (00:15:46) attention to themselves. They want to say, well, the thing I'm working on is really amazing. And the reality is that, you know, this is just software. It's, it's, it's not, uh, the end of the world. It is the most important kind of software ever made, as you said earlier, but it's not going to kill us all. Uh, Dario also said that we'd be fully unemployed within, you know, one to five years, about two years ago. Well, he's got three years left. Uh, he also said that we'd cure all diseases. I don't think there'll be a single AI relevant drug in the next 10 years. Um, AI does not help drug discovery. If you've ever built drugs and raise your hand, if you've made a drug, gotten FDA approval for a drug. Okay. I'm pretty sure that's it. Um, you know, it's pretty hard. Uh, it's pretty hard to do. And, and we've had computers for a long time. I built a Cray cluster to analyze drugs. Now I can use, you know, GPUs. (00:16:31) It's great, but there isn't much AI can help us with in drug discovery. What is, what is the revenue cycle that's driving valuation? So just unpack it from a hedge funder. You're sitting there. You're like, well, you see these run rates, right? Um, I think Jensen mentioned it yesterday, $400 billion have gone into venture that has been redirected into AI. So do you interpret that as VCs funneling LP money to buy tokens effectively? Yeah, I think so. And, and that's your argument. Yeah. And I think you're going to have one. There's a valuation trap in there. Do you think? I don't think so. I think that what you mentioned earlier, productivity, I mean, there is infinite demand for intelligence and infinite demand for work. You know, when you said the workforce, I said, I think Brad's making a mistake here because if you take the TAM and limit it to knowledge workers, you're really undercutting (00:17:17) the TAM. And you know, the, there's trying to be conservative. Yeah. There's, there's no limit towards intelligence. One example I used to give and, um, my, my buddy started left a open AI and started a company called core automation, which we're really excited about. I think I mentioned the other night, um, he invented the reasoning model at open AI and he's got a somewhat under the radar startup. Um, I think that you're going to have AI starting businesses. And that's, I think part of his plan is to, is to have within, you know, open AI, open AI pharma, open AI motors, open AI aviation, open AI, et cetera. And, you know, he will have his versions of those. And you're going to have a whole S and P 500 within open AI or anthropic or wherever. Um, so I think that the opportunities are boundless. And one last thing is that McDonald's can afford to spend $10 billion and say open AI, (00:18:07) give me 10 million GPUs. I want to know what the best next sandwich we should launch is. And that's an NPV positive. You know, uh, if the intelligence is worth it, if it's not asymptotic at some point, you know, more tokens doesn't get you a better answer. But, you know, when that day comes where, where you say, you know, instead of hiring McKinsey or focus group, I need 10 million GPU minds to think about what is, what should McDonald's do right now? What is a good analog for the open AI? Oh, sorry, for the AI marketplace. Meaning you see a handful of providers of a critical resource. You see incredible valuations that obviously attracts a lot of people. That obviously attracts a lot of incremental capital. It, that breeds a lot of competition. There's various different solutions. Jensen made the analogy yesterday of like, it's kind of like water. You still have $8 water, but you still have the free water. And there's a, there's a world in which, you know, all flowers bloom. (00:18:52) What's your mental model? How do you equate this to previous markets that, that we would understand oil or other It has to be like the internet. I, you know, at least part of it, you know, has to be like the internet where the only winners specifically, yeah, the only winners can be consumers and businesses. They get this tax free kind of internet Cisco and some other guys will get a little bit out of it. But the main highway that we're all going to benefit from, which we already are as we have free intelligence in our pocket. So, but that I would interpret that what you're saying then is like, we have to now right now be guessing around a who's going to over earn and be the duration of that over earning. Sure. And I think it's meta timing. I think it's meta. Meaning the company. Yeah, they have, they have, they have, why is that they have the distribution with Muse. They showed that they still have product chops. I think we're still in day one of, of AI. (00:19:37) I actually think that, you know, the chat bots are this, we're going to look back and laugh and say, these are the early. Would you own, would you go out today and buy open AI and Anthropic? Yeah. Yeah. So we have open AI obviously through, through, through a few different ways. And I think that Sam's hedge with hardware is, is really brilliant because the, you know, he'll always have the best model, I think, but being able to deliver that model is probably to be more valuable than, you know, and that's where we saw with Muse, you know, this really creative product work that, that, that Alex did shows a, you know, a new avenue for them. What did you think about Elon's suggestion of competitor peer review as kind of this third way, this middle ground, pragmatic solution to balancing safety and, and speed? (00:20:22) You know, they said that the Wright brothers, if Warren Buffett could go back in time, he'd go back and shoot the Wright brothers and stop the aviation industry from ruining capitalism. I think that Nick Bostrom wrote this book, Super Intelligence, that scared the hell out of Elon. And, you know, maybe I'm not advocating for violence, but you know, it would, it would have been better if some of the EA kind of folks never sort of had this like narcissistic kind of self-importance that is driving some of these fear mongering. And I think opening, I doesn't believe it. I think they're in this as wanting to not be too different from, uh, anthropic. Uh, thankfully, you know, some other guys have the spine. Meta has the spine to call it out and say, this is nonsense. The president has the spine to do the same. Jensen has the spine to do the same. It's just computer science. It's not that big of a deal. Some of these EA guys are pretty brilliant. (00:21:08) Uh, Dario's no dummy. Dustin Moskovitz, um, Sam Bankman-Fried. Sometimes you can be really smart at one thing and really dumb at another. Let me ask you this question. Do you think, and I actually, yeah. I'm a good example. Well, so this is, this is actually my point. I feel like some of the smartest people are unconventional thinkers. And you're, you're clearly a brilliant person. People that are brilliant are generally brilliant because they're not conventional. They're, they're, they're, they're heterodox in some way. But in the same vein, if you have that brilliance, perhaps it's also hard for you to be conventional in the ways that are perhaps call it law abiding. And, um, yeah, by the way, I just want to say, hold on one sec. Hold on one sec, hold on one sec. (00:21:53) So I just like, so I want to just ask your opinion on Sam Bankman-Fried. Yeah. So you've met the guy, you, you were, uh, I think, right? I give him advice, yeah. You give him advice on how to tough it out. But can you just give us your sense on the guy, you know, he was early in Anthropic at the beginning. You look at the, you look at the portfolio of investments he made. Robin Hood. You look at the portfolio of investments he made across the board. It was crazy in 2021, 2022. It looked like and genius. Yeah. Genius. Can you just tell us a little bit about what got that guy off track? Is it that he was so out of the bounds as a thinker? That's what got him all the alpha, but in the same way, it also got him in trouble. Or was it speed? Yeah, I think, I think it's both. You know, I think the, one of the problems, if you grow up as a intellectually gifted person, (00:22:40) you have this big albatross. I think it's happened as well to Elizabeth Holmes. You know, Raj Rajatnam is another example of a head for manager that was a decent investor. You know, it was much more that he, you know, I think, you know, to keep it short, you have this self-conscious, you have to live up to something. And sometimes wanting to live up to that big thing can be very detrimental. And just failing and admitting that you are not that great at that is not that bad. I had a hard time admitting I was not the best head for manager in the world, but I was a wonderful entrepreneur. That simple refusal to admit that put me in prison. Have you changed your views or behavior? Like, what has changed about you from prison? Like, what's the change? I think that, you know, psychology is a really powerful force. You know, we all do things. (00:23:26) All of our actions are motivated by some innate drives that we don't always understand. You know, I didn't realize how petrified I was of not being seen as a great trader. What a stupid thing. You know, what a big deal. You know, you can be a great long-term investor, value investor, entrepreneur, you know, startup guy, whatever. Dad. What's up? Dad. Yeah, a great dad. A great scientist, whatever. You know, but if you really, like, fixate your own mind on, I have to be this, then that can be really detrimental. Putting aside your case, valid or not, you know, if you were targeted for whatever reasons, what did you learn during your time in the big house? And how did it change you as a person? Because you're very different. You know, you seem to have gotten a lot sharper and a little bit more methodical in your approach to life. (00:24:16) So take us through what you learned in that time. Thanks a lot. I think that the, one of the interesting things about prison is no matter where anybody's from or what they did or whatever, everyone sort of has a lot of these same real common features that bind us as humans. Everyone's sort of upset that their friend didn't stay in touch or longing for that person that, you know, they miss or whatever the case is. And it's really refreshing, you know, to remember that, you know, we're, you know, no matter what heights we achieve, that at bottom, you know, like you said earlier, we all want to be the best dad we can or whatever the case is. Martin, you're, you're, you're, look, I think you're just a very independent thinker and you're also, you're willing to say the things and communicate in a way that other people don't. That's why we wanted to have you here. And I think obviously this was a great showcase of that. (00:25:04) We really appreciate you taking the time to be with us. Thank you so much. Yeah, it's great. Thanks, Bert. Nice to meet you. Nice to meet you. Hey man, come back anytime. I'll see you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you.

本集资源与出处